Goldman Sachs
June 12, 2026
Healthcare Conference Wrap-Up Key Themes And Takeaways
Market ReportEquitiesHealth Care
The report provides a comprehensive summary of the 47th Annual Global Healthcare Conference, highlighting key trends in M&A, AI integration, and obesity/cardiology therapeutics.
Key Takeaways
- 1.Investor sentiment is bullish on biotech but bearish on hospitals, characterized by low participation and a lack of conviction.
- 2.M&A remains a strategic priority for biopharma, with companies actively scanning for commercial or near-commercial stage assets.
- 3.AI is increasingly viewed as an operational efficiency tool to drive cost reductions and potentially revenue growth, rather than just a cost-cutting mechanism.
Table of Contents
- PM Summary
- Large Cap Biopharma
- Non-Therapeutics (MedTech, Services, Tools, Diagnostics, HCIT)
- US Pharma
- EU Pharma
- Generic/Spec Pharma
- Biotech
- SMID Biotech
- US Medtech and HCIT
- Clinical catalysts
- EU Medtech
- Life Science Tools & Diagnostics
- Healthcare Services & Providers
Access the Full Report
Get unlimited access to institutional research reports with a 14-day free trial.
Authors
Asad Haider, CFASalveen Richter
Securities
ABBVLLY
Themes
M&A and Business DevelopmentAI in Drug DevelopmentObesity and Cardiology Renaissance
Regions
GlobalEuropeUnited StatesChinaJapan